borderline significantp = 0.07
More tumors among long-term survivors had high CD8+ expression compared to tumors among short-term survivors, 63% (12/19) and 35% (8 /23), respectively and this difference was borderline significant ( p = 0.07).
More tumors among long-term survivors had high CD8+ expression compared to tumors among short-term survivors, 63% (12/19) and 35% (8 /23), respectively and this difference was borderline significant ( p = 0.07).
A highly significant trend for a longer survival was found in the presence of an increasing number of markers; CD8+ and FOXP3+ T cells, low tumor proliferation and BRAF wildtype status ( p = 0.003).